Hints and tips:
...Quest Diagnostics, the largest laboratory company in the US, this week warned that there was “no way” the industry could expand molecular nasal swab testing capacity in time for the autumn, when demand is...
...The Dutch group makes molecular testing equipment and has developed Covid-19 test kits for research purposes....
...Thierry Bernard, Qiagen chief executive, said: “The rationale for this strategic step is stronger than ever, especially as the value of molecular testing becomes ever more evident.”...
...The test runs on the company’s portable platform, which is the most widely available point-of-care molecular testing device in the US....
...Mr Kulkarni said the sector would become more like “Apple v Samsung”, where biotechs competed on adding generation after generation of features....
...DD’s Indap v NYU’s Damodaran: Is stock compensation good or bad?...
...There, a urologist uses a molecular diagnostic test to look for biomarkers indicating the presence of the disease....
...“More and more I think we’ll be defining tumours in a [molecular] way.” Molecular testing is already commonplace in cancers such as lung and breast, where doctors identify each mutation in turn....
...Mr You, who has a masters degree in biochemistry and molecular biology, suggests tightening regulations on health records to make it harder to transfer them overseas....
...An area where growth is more exciting is molecular diagnostics, but valuations in this field are racier — Illumina, pursued in 2013 by Swiss pharma group Roche, trades at a heady six times forecast sales...
...An emerging cancer diagnostics area is based on the detection of epigenetic biomarkers associated with cancer....
...The growing understanding of the molecular pathways behind diseases is combining with the second important trend: the convergence of healthcare and digital technology that is bringing more precision and...
...The dream of a seamless network is a long way off, says Jurgi Camblong, chief executive of Sophia Genetics, a Swiss diagnostics company....
...Some critics say there is too much focus on new drugs at the expense of spending on prevention, diagnostics and palliative care....
...One diagnostics company said: “This is a clear victory for Myriad because the Supreme Court left cDNA intact.”...
...Rob Cascella, chief executive of Hologic, said: “With the addition of this product line and these products, we feel that we’re positioned to now have a high-growth molecular business and overall diagnostic...
...CA Inc climbed 9.6 per cent to $25.02 as the software developer easily beat analyst expectations....
...Using molecular diagnostics, “we can stratify patients, who to treat and who not to treat, and what specific drugs will work best.”...
...The two firms will be evaluating Epistem’s handheld Genedrive molecular device to identify TB infection at an early age....
...Danaher, the acquisitive US conglomerate, has launched its biggest takeover deal, agreeing to buy Beckman Coulter, a diagnostic equipment maker, for $6.8bn, as it seeks to expand in the life sciences testing...
...But Pascale Witz, head of the $2bn medical diagnostics sub-division which will absorb the new business, expects that the Clarient acquisition will enable molecular testing sales to grow to $1bn with the...
...Molecular Profiles Nottingham Website: www.molprofiles.com Employees: 34 Chief executive: Nikin Patel An innovation award is made to Molecular Profiles for the creation of cutting-edge analytical services...
...The report stresses the potential to increase efficacy and value in a way sought by healthcare systems and insurers – from integrating drugs with genetic markets, imaging and molecular markers, and with...
...The company is focused on higher-growth areas, including medical technology, life sciences and diagnostics....
...There was “a potentially larger pool of investors in the US than in the UK”, and US investors had “a better understanding of the molecular diagnostics industry”....
International Edition